LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 39

Search options

  1. Article ; Online: Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: a mixed methods systematic review and meta-analysis.

    Maynard, Claire / Tariq, Shema / Sotgiu, Giovanni / Migliori, Giovanni Battista / van den Boom, Martin / Field, Nigel

    EClinicalMedicine

    2023  Volume 61, Page(s) 102057

    Abstract: Background: People with tuberculosis (TB) face multi-dimensional barriers when accessing and engaging with care. There is evidence that providing psychosocial support within people-centered models of care can improve TB outcomes, however, there is ... ...

    Abstract Background: People with tuberculosis (TB) face multi-dimensional barriers when accessing and engaging with care. There is evidence that providing psychosocial support within people-centered models of care can improve TB outcomes, however, there is limited consensus on what works. It remains important for such interventions to be rigorously assessed, and mixed methods systematic reviews are one way of synthesising data for policy makers to be able to access such evidence. Mixed methods reviews take a complexity perspective, with qualitative data being used to contextualise the quantitative findings and giving an insight into how interventions are contingent on variations in design and context.
    Methods: Five electronic databases were searched from January 1 2015 to 14 January 2023 for randomised controlled trials, quasi-experimental trials, cohort studies and qualitative studies of interventions providing psychosocial support (material and/or psychological-based support) to adults with any clinical form of active TB. Studies with inpatient treatment as the standard of care were excluded. Quantitative studies reporting pre-specified standard TB outcomes were eligible. In line with established mixed methods review methodology, a convergent parallel-results synthesis design was followed: quantitative and qualitative syntheses were distinct and carried out using appropriate methods. A convergent coding matrix was then used to integrate the results. The protocol was registered on PROSPERO (CRD42021235211).
    Findings: Twenty-three studies of interventions were included (12 quantitative, 10 qualitative, and 1 mixed methods study) were included. Most studies were conducted in low-and middle-income countries with a high-burden of TB. Three explanatory and contextual middle-range theories from the integration of qualitative and quantitative data were developed: effective interventions provide multi-dimensional support; psychological-based support is transformative but there is insufficient evidence that it improves treatment outcomes on its own; intervention delivery shapes a logic of care.
    Interpretation: This review takes a complexity perspective to provide actionable and timely insight to inform the design and implementation of locally-appropriate and people-centered psychosocial support interventions within national TB programmes.
    Funding: There was no funding source for this study.
    Language English
    Publishing date 2023-06-27
    Publishing country England
    Document type Journal Article
    ISSN 2589-5370
    ISSN (online) 2589-5370
    DOI 10.1016/j.eclinm.2023.102057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Drug resistant TB - latest developments in epidemiology, diagnostics and management.

    Tiberi, Simon / Utjesanovic, Natasa / Galvin, Jessica / Centis, Rosella / D'Ambrosio, Lia / van den Boom, Martin / Zumla, Alimuddin / Migliori, Giovanni Battista

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

    2022  Volume 124 Suppl 1, Page(s) S20–S25

    Abstract: Aim: The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management.: Epidemiology: Drug-resistant Tuberculosis (DR-TB) continues to be a current global health threat, and is defined by higher ... ...

    Abstract Aim: The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management.
    Epidemiology: Drug-resistant Tuberculosis (DR-TB) continues to be a current global health threat, and is defined by higher morbidity and mortality, sequelae, higher cost and complexity. The WHO classifies drug-resistant TB into 5 categories: isoniazid-resistant TB, rifampicin resistant (RR)-TB and MDR-TB, (TB resistant to isoniazid and rifampicin), pre-extensively drug-resistant TB (pre-XDR-TB) which is MDR-TB with resistance to a fluoroquinolone and finally XDR-TB that is TB resistant to rifampicin, plus any fluoroquinolone, plus at least one further priority A drug (bedaquiline or linezolid). Of 500,000 estimated new cases of RR-TB in 2020, only 157 903 cases are notified. Only about a third of cases are detected and treated annually.
    Diagnostics: Recently newer rapid diagnostic methods like the GeneXpert, whole genome sequencing and Myc-TB offer solutions for rapid detection of resistance.
    Treatment: The availability of new TB drugs and shorter treatment regimens have been recommended for the management of DR-TB.
    Conclusion: Despite advances in diagnostics and treatments we still have to find and treat two thirds of the drug resistant cases that go undetected and therefore go untreated each year. Control of TB and elimination will only occur if cases are detected, diagnosed and treated promptly.
    Language English
    Publishing date 2022-03-25
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 1331197-9
    ISSN 1878-3511 ; 1201-9712
    ISSN (online) 1878-3511
    ISSN 1201-9712
    DOI 10.1016/j.ijid.2022.03.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Prioritising children and adolescents in the tuberculosis response of the WHO European Region.

    Gröschel, Matthias I / van den Boom, Martin / Migliori, Giovanni Battista / Dara, Masoud

    European respiratory review : an official journal of the European Respiratory Society

    2019  Volume 28, Issue 151

    Abstract: In 2017, in recognition of the challenges faced by Member States in managing childhood and adolescent tuberculosis (TB) at a country level, the WHO Regional Office for Europe held a Regional Consultation. In total, 35 countries participated in the ... ...

    Abstract In 2017, in recognition of the challenges faced by Member States in managing childhood and adolescent tuberculosis (TB) at a country level, the WHO Regional Office for Europe held a Regional Consultation. In total, 35 countries participated in the consultations representing both high- and low-incidence Member States. Here, we provide an overview of the existing World Health Organization (WHO) documents and guidelines on childhood and adolescent TB and describe the outcomes of this regional meeting. National childhood and adolescent TB guidelines are available in 25% of Member States, while 33% reported that no such guidelines are at hand. In the majority of countries (83%), childhood and adolescent TB is part of the National Strategic Plan. The most pressing challenges in managing paediatric TB comprise the lack of adequate drug formulations, the difficult diagnosis, and treatment of presumed latent TB infection. Investments into childhood and adolescent TB need to be further advocated to achieve the End TB goals set by WHO to eliminate TB by 2030.
    MeSH term(s) Adolescent ; Age Distribution ; Antitubercular Agents/therapeutic use ; Child ; Europe/epidemiology ; Female ; Health Priorities/organization & administration ; Health Services Needs and Demand/organization & administration ; Humans ; Male ; Needs Assessment/organization & administration ; Practice Guidelines as Topic ; Regional Health Planning/organization & administration ; Tuberculosis/diagnosis ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology ; Tuberculosis/microbiology ; World Health Organization/organization & administration
    Chemical Substances Antitubercular Agents
    Language English
    Publishing date 2019-03-14
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1077620-5
    ISSN 1600-0617 ; 0905-9180
    ISSN (online) 1600-0617
    ISSN 0905-9180
    DOI 10.1183/16000617.0106-2018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The role of novel molecular techniques for tuberculosis diagnostics in the WHO European Region.

    Ehsani, Soudeh / van den Boom, Martin / Gilpin, Christopher / Dara, Masoud

    Journal of public health (Oxford, England)

    2017  Volume 38, Issue 4, Page(s) 824–825

    MeSH term(s) Ethnicity ; Humans ; Molecular Diagnostic Techniques/methods ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/isolation & purification ; Tuberculosis/diagnosis
    Language English
    Publishing date 2017-02-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2142082-8
    ISSN 1741-3850 ; 1741-3842
    ISSN (online) 1741-3850
    ISSN 1741-3842
    DOI 10.1093/pubmed/fdv200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book ; Online: Обзор готовности к переходу на государственное финансирование мероприятий по противодействию эпидемии ТБ в Республике Беларусь

    van den Boom, Martin / Nasidze, Nikoloz / Attwill, Allira

    25–28 марта 2018 г.: доклад по итогам миссии

    2018  

    Abstract: 45 c. ... Европейское региональное бюро ВОЗ проводит оценку готовности к переходу от финансирования Глобальным фондом для борьбы со СПИДом, туберкулезом и малярией (ГФСТМ) мероприятий по борьбе с туберкулезом в шести отдельных странах (Азербайджане, ... ...

    Abstract 45 c.

    Европейское региональное бюро ВОЗ проводит оценку готовности к переходу от финансирования Глобальным фондом для борьбы со СПИДом, туберкулезом и малярией (ГФСТМ) мероприятий по борьбе с туберкулезом в шести отдельных странах (Азербайджане, Армении, Беларуси, Грузии, Республике Молдове и Украине) к финансированию за счет средств государственного бюджета в контексте общего сокращения внешнего донорского финансирования. Цель этой работы – предоставление поддержки странам в документировании их готовности к переходу от донорского финансирования деятельности по противодействию эпидемии туберкулеза к внутреннему финансированию на национальном уровне, и оказание заинтересованным сторонам в стране помощи в определении и осуществлении первоочередных мер переходного периода. В рамках этой работы в период с 25 по 28 марта 2018 г. два эксперта ВОЗ посетили Беларусь для проведения третьего раунда обсуждений и оценки данного проекта ВОЗ внутри страны. В настоящем докладе представлен обзор переходного процесса в Беларуси, некоторые аспекты обеспечения устойчивости, проблемы, связанные с прекращением донорского финансирования противотуберкулезной деятельности, даны рекомендации по преодолению трудностей переходного периода и обеспечению устойчивости.
    Keywords Tuberculosis ; Republic of Belarus ; Sustainable Development ; Community Health Planning ; Communicable Diseases
    Language Russian
    Publisher Всемирная организация здравоохранения. Европейское региональное бюро
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis.

    Migliori, Giovanni Battista / Caminero Luna, Jose' / Kurhasani, Xhevat / van den Boom, Martin / Visca, Dina / D'Ambrosio, Lia / Centis, Rosella / Tiberi, Simon

    Presse medicale (Paris, France : 1983)

    2022  Volume 51, Issue 3, Page(s) 104112

    Abstract: Tuberculosis (TB), known as the White Plague' is of great significance to humanity for the magnitude of morbidity and mortality it has generated over centuries from the very start of human civilization. In this Review, we will describe the history of ... ...

    Abstract Tuberculosis (TB), known as the White Plague' is of great significance to humanity for the magnitude of morbidity and mortality it has generated over centuries from the very start of human civilization. In this Review, we will describe the history of prevention (vaccination and management of TB infection), diagnosis, treatment and pulmonary rehabilitation of post-treatment sequelae. The article leads the reader through the main discoveries which paved the way to the modern approach to TB prevention and care. The history of Bacille Calmette-Guérin (BCG) vaccine and of the diagnosis and treatment of TB infection are presented, together with that of diagnosis and treatment of TB disease. Pivotal was in 1882 the discovery by Robert Koch of the aetiological agent of TB, and his pioneering work in culturing the bacillus and developing tuberculin. Also of enormous importance was, in 1895, the discovery of the X-rays by Wilhelm Conrad Röntgen, discovery which paved the way to the development of the modern imaging technologies. To complement this, the more recent history of rehabilitation of post-treatment sequelae is summarized, given the importance this issue has on patients' wellbeing and Quality of Life.
    Language English
    Publishing date 2022-02-04
    Publishing country France
    Document type Journal Article
    ZDB-ID 120943-7
    ISSN 2213-0276 ; 0032-7867 ; 0755-4982 ; 0301-1518
    ISSN (online) 2213-0276
    ISSN 0032-7867 ; 0755-4982 ; 0301-1518
    DOI 10.1016/j.lpm.2022.104112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: People-centred care versus clinic-based DOT for continuation phase TB treatment in Armenia: a cluster randomized trial.

    Khachadourian, Vahe / Truzyan, Nune / Harutyunyan, Arusyak / Petrosyan, Varduhi / Davtyan, Hayk / Davtyan, Karapet / van den Boom, Martin / Thompson, Michael E

    BMC pulmonary medicine

    2020  Volume 20, Issue 1, Page(s) 105

    Abstract: Background: WHO's directly observed therapy (DOT) strategy for tuberculosis (TB) treatment depends upon a well-organized healthcare system. This study sought to evaluate the effectiveness of self-administered drug intake supported by a family member ... ...

    Abstract Background: WHO's directly observed therapy (DOT) strategy for tuberculosis (TB) treatment depends upon a well-organized healthcare system. This study sought to evaluate the effectiveness of self-administered drug intake supported by a family member versus in-clinic DOT.
    Methods: This open-label, nationally-representative stratified cluster randomized controlled non-inferiority trial with two parallel equal arms involved drug-susceptible pulmonary TB patients in the continuation treatment phase. We randomly assigned outpatient-TB-centres (52 clusters) to intervention and control arms. The intervention included an educational/counseling session to enhance treatment adherence; weekly visits to outpatient-TB-centres to receive medication, and daily SMS medication reminders and phone calls to track adherence and record side effects. Controls followed clinical DOT at Outpatient-TB-centres. Both groups participated in baseline and 4-5 months follow-up surveys. The trial's non-inferiority comparisons include: treatment success as the clinical (primary) outcome and medication adherence (self-reported), knowledge, depressive symptoms, stigma, quality of life, and social support as non-clinical (secondary) outcomes.
    Results: Per-protocol analysis showed that the intervention (n = 187) and control (n = 198) arms achieved successful treatment outcome of 92.0 and 92.9%, respectively, indicating that the treatment success in the intervention group was non-inferior to DOT. Knowledge, depression, stigma, quality of life, and social support also showed non-inferiority, demonstrating substantial improvement over time for knowledge (change in the intervention = 1.05: 95%CL (0.49, 1.60); change in the control = 1.09: 95%CL (0.56, 1.64)), depression score (change in the intervention = - 3.56: 95%CL (- 4.99, - 2.13); change in the control = - 1.88: 95% CL (- 3.26, - 0.49)) and quality of life (change in the intervention = 5.01: 95%CL (- 0.64, 10.66); change in the control = 7.29: 95%CL (1.77, 12.81)). The intervention resulted in improved treatment adherence.
    Conclusions: This socially empowering alternative strategy might be a preferable alternative to DOT available to patients in Armenia and in other countries. Further research evaluating cost effectiveness of the intervention and generalizability of the results is warranted.
    Trial registration: Clinicaltrials.gov: NCT02082340, March 10, 2014.
    MeSH term(s) Adult ; Antitubercular Agents/therapeutic use ; Armenia ; Counseling ; Directly Observed Therapy ; Female ; Humans ; Male ; Middle Aged ; Patient-Centered Care/methods ; Quality of Life ; Social Support ; Telephone ; Treatment Outcome ; Tuberculosis, Pulmonary/drug therapy
    Chemical Substances Antitubercular Agents
    Language English
    Publishing date 2020-04-25
    Publishing country England
    Document type Comparative Study ; Equivalence Trial ; Journal Article ; Multicenter Study
    ZDB-ID 2059871-3
    ISSN 1471-2466 ; 1471-2466
    ISSN (online) 1471-2466
    ISSN 1471-2466
    DOI 10.1186/s12890-020-1141-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: What is behind programmatic treatment outcome definitions for tuberculosis?

    Avaliani, Zaza / Gozalov, Ogtay / Kuchukhidze, Giorgi / Skrahina, Alena / Soltan, Viorel / van den Boom, Martin / Vasilyeva, Irina / Vilc, Valentina / Yedilbayev, Askar

    The European respiratory journal

    2020  Volume 56, Issue 1

    MeSH term(s) Antitubercular Agents/therapeutic use ; Humans ; Treatment Outcome ; Tuberculosis/diagnosis ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology ; Tuberculosis, Multidrug-Resistant/drug therapy
    Chemical Substances Antitubercular Agents
    Language English
    Publishing date 2020-07-23
    Publishing country England
    Document type Editorial
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.01751-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence.

    Migliori, Giovanni Battista / Visca, Dina / van den Boom, Martin / Tiberi, Simon / Silva, Denise Rossato / Centis, Rosella / D'Ambrosio, Lia / Thomas, Tania / Pontali, Emanuele / Saderi, Laura / Schaaf, H Simon / Sotgiu, Giovanni

    Pulmonology

    2021  Volume 27, Issue 3, Page(s) 248–256

    Abstract: The scientific debate on the criteria guiding hospitalization of tuberculosis (TB) and COVID-19 patients is ongoing. The aim of this review is to present the available evidence on admission for TB and TB/COVID-19 patients and discuss the criteria guiding ...

    Abstract The scientific debate on the criteria guiding hospitalization of tuberculosis (TB) and COVID-19 patients is ongoing. The aim of this review is to present the available evidence on admission for TB and TB/COVID-19 patients and discuss the criteria guiding hospitalization. Furthermore, recommendations are made as derived from recently published World Health Organization documents, based on Global Tuberculosis Network (GTN) expert opinion. The core published documents and guidelines on the topic have been reviewed. The proportion of new TB cases admitted to hospital ranges between 50% and 100% while for multidrug-resistant (MDR) TB patients it ranges between 85 and 100% globally. For TB patients with COVID-19 the proportion of cases admitted is 58%, probably reflecting different scenarios related to the diagnosis of COVID-19 before, after or at the same time of the active TB episode. The hospital length of stay for drug-susceptible TB ranges from 20 to 60 days in most of countries, ranging from a mean of 10 days (USA) to around 90 days in the Russian Federation. Hospitalization is longer for MDR-TB (50-180 days). The most frequently stated reasons for recommending hospital admission include: severe TB, infection control concerns, co-morbidities and drug adverse events which cannot be managed at out-patient level. The review also provides suggestions on hospital requirements for safe admissions as well as patient discharge criteria, while underlining the relevance of patient-centred care through community/home-based care.
    MeSH term(s) COVID-19/complications ; COVID-19/therapy ; Consensus ; Hospitalization/statistics & numerical data ; Humans ; Length of Stay/statistics & numerical data ; Practice Guidelines as Topic ; SARS-CoV-2 ; Tuberculosis/complications ; Tuberculosis/therapy
    Language English
    Publishing date 2021-01-28
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 3009651-0
    ISSN 2531-0437 ; 2531-0429
    ISSN (online) 2531-0437
    ISSN 2531-0429
    DOI 10.1016/j.pulmoe.2020.12.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: European guidance on drug-resistant tuberculosis in children and adolescents.

    Gröschel, Matthias I / Seddon, James A / Prabowo, Satria A / Migliori, Giovanni B / Graham, Stephen M / van den Boom, Martin / Dara, Masoud

    The Lancet. Child & adolescent health

    2019  Volume 4, Issue 1, Page(s) 9–11

    MeSH term(s) Adolescent ; Antitubercular Agents/therapeutic use ; Child ; Europe ; Humans ; Practice Guidelines as Topic ; Tuberculosis, Multidrug-Resistant/diagnosis ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Multidrug-Resistant/prevention & control ; World Health Organization
    Chemical Substances Antitubercular Agents
    Language English
    Publishing date 2019-10-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2352-4650
    ISSN (online) 2352-4650
    DOI 10.1016/S2352-4642(19)30332-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top